Literature DB >> 22116685

Primary and probable secondary dengue virus (DV) infection rates in relation to age among DV IgM-positive patients residing in the United States mainland versus the Caribbean islands.

Harry E Prince1, Cindy Yeh, Mary Lapé-Nixon.   

Abstract

Dengue virus (DV) primary infection and probable secondary infection rates in relation to patient age (years) were determined for DV IgM-positive U.S. mainland residents (presumed travelers to areas of DV endemicity) and Caribbean island (area of DV endemicity) residents by evaluating IgG status and IgG avidity. Regardless of place of residence, most patients ≤20 years old exhibited primary infection and most patients >60 years old exhibited probable secondary infection. Among patients 21 to 60 years old, the primary infection rate was markedly higher in U.S. residents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116685      PMCID: PMC3255955          DOI: 10.1128/CVI.05519-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  33 in total

1.  Fatal and mild primary dengue virus infections imported to Norway from Africa and south-east Asia, 2008-2010.

Authors:  K Vainio; S Noraas; M Holmberg; H Fremstad; M Wahlstrøm; G Anestad; S Dudman
Journal:  Euro Surveill       Date:  2010-09-23

2.  Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample.

Authors:  Séverine Matheus; Xavier Deparis; Bhety Labeau; Josiane Lelarge; Jacques Morvan; Philippe Dussart
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay.

Authors:  A Sa-Ngasang; S Anantapreecha; A A-Nuegoonpipat; S Chanama; S Wibulwattanakij; K Pattanakul; P Sawanpanyalert; I Kurane
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

4.  Patterns of dengue virus IgM and IgG antibodies in suspected cases of dengue in Jamaica, 2003-2006.

Authors:  Michelle G Brown; Ivan E Vickers; Rose Alba Salas; Monica Fisher Smikle
Journal:  Hum Antibodies       Date:  2009

5.  Dengue in the early febrile phase: viremia and antibody responses.

Authors:  D W Vaughn; S Green; S Kalayanarooj; B L Innis; S Nimmannitya; S Suntayakorn; A L Rothman; F A Ennis; A Nisalak
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

6.  Dengue seroconversion among Israeli travelers to tropical countries.

Authors:  I Potasman; I Srugo; E Schwartz
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

7.  Description of a large island-wide outbreak of dengue in Puerto Rico, 2007.

Authors:  Kay M Tomashek; Aidsa Rivera; Jorge L Muñoz-Jordan; Elizabeth Hunsperger; Luis Santiago; Oscar Padro; Enid Garcia; Wellington Sun
Journal:  Am J Trop Med Hyg       Date:  2009-09       Impact factor: 2.345

8.  Evaluation of the Panbio dengue virus nonstructural 1 antigen detection and immunoglobulin M antibody enzyme-linked immunosorbent assays for the diagnosis of acute dengue infections in Laos.

Authors:  Stuart D Blacksell; Mammen P Mammen; Soulignasack Thongpaseuth; Robert V Gibbons; Richard G Jarman; Kemajittra Jenjaroen; Ananda Nisalak; Rattanaphone Phetsouvanh; Paul N Newton; Nicholas P J Day
Journal:  Diagn Microbiol Infect Dis       Date:  2007-09-24       Impact factor: 2.803

9.  Seroprevalence of IgG specific for dengue virus among adults and children in Santo Domingo, Dominican Republic.

Authors:  Tetsu Yamashiro; Mildre Disla; Angela Petit; Delfis Taveras; Mercedez Castro-Bello; Miguel Lora-Orste; Sonia Vardez; Ana Julia Cesin; Barbara Garcia; Akira Nishizono
Journal:  Am J Trop Med Hyg       Date:  2004-08       Impact factor: 2.345

Review 10.  Dengue: the risk to developed and developing countries.

Authors:  T P Monath
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

View more
  4 in total

Review 1.  Staphylococcus aureus pneumonia and dengue virus co-infection and review of implications of coinfection.

Authors:  Rajeev Peeyush Nagassar; Roma Jaanki Bridgelal-Nagassar; Nathlee McMorris; Nathalie Mc Morris; Karen Judith Roye-Green
Journal:  BMJ Case Rep       Date:  2012-07-03

2.  Prospective evaluation of the SD BIOLINE Dengue Duo rapid test during a dengue virus epidemic.

Authors:  C Simonnet; A Okandze; S Matheus; F Djossou; M Nacher; A Mahamat
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-22       Impact factor: 3.267

3.  Emergence of the Asian lineage dengue virus type 3 genotype III in Malaysia.

Authors:  Kim-Kee Tan; Nurul-Izzani Zulkifle; Syuhaida Sulaiman; Sui-Ping Pang; NurAsyura NorAmdan; NorAziyah MatRahim; Juraina Abd-Jamil; Meng-Hooi Shu; Nor Muhammad Mahadi; Sazaly AbuBakar
Journal:  BMC Evol Biol       Date:  2018-04-24       Impact factor: 3.260

4.  Dengue Fever and Severe Dengue in Barbados, 2008-2016.

Authors:  Kirk Osmond Douglas; Sudip Kumar Dutta; Byron Martina; Fatih Anfasa; T Alafia Samuels; Marquita Gittens-St Hilaire
Journal:  Trop Med Infect Dis       Date:  2020-05-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.